Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott E Martin

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Nucleic Acids Research|March 30, 2007
Multiplexing siRNAs to compress RNAi-based screen size in human cellsScott E Martin, Tamara L Jones, Cheryl L Thomas, et al.
Nature Communications|February 24, 2016
An interactive web-based application for Comprehensive Analysis of RNAi-screen DataBhaskar Dutta, Alaleh Azhir, Louis-Henri Merino, et al.
Plos Pathogens|December 8, 2016
Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus SpreadMasfique Mehedi, Thomas McCarty, Scott E Martin, et al.
Science Signaling|August 21, 2020
Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instabilitySuhas S Kharat, Xia Ding, Divya Swaminathan, et al.
Molecular Cancer Therapeutics|July 8, 2025
KRAS codon-specific mutations differentially toggle PI3K pathway signaling and alter sensitivity to inavolisib (GDC-0077)Kyung W Song, Christy C Ong, Eva Lin, et al.
Cancer Letters|September 7, 2014
Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activityOliver Ou, Konrad Huppi, Sirisha Chakka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung AdenocarcinomaAnneleen Daemen, Jonathan E Cooper, Szymon Myrta, et al.
Molecular Cancer Therapeutics|March 5, 2020
CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing SarcomaGuillermo Flores, Joel H Everett, Elissa A Boguslawski, et al.
Cancer Cell|October 10, 2018
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant TumorsIvana Yen, Frances Shanahan, Mark Merchant, et al.
Cancer Discovery|November 19, 2020
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK PathwaysTrang H Pham, Thijs J Hagenbeek, Ho-June Lee, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Nucleic Acids Research|March 30, 2007
Multiplexing siRNAs to compress RNAi-based screen size in human cellsScott E Martin, Tamara L Jones, Cheryl L Thomas, et al.
Nature Communications|February 24, 2016
An interactive web-based application for Comprehensive Analysis of RNAi-screen DataBhaskar Dutta, Alaleh Azhir, Louis-Henri Merino, et al.
Plos Pathogens|December 8, 2016
Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus SpreadMasfique Mehedi, Thomas McCarty, Scott E Martin, et al.
Science Signaling|August 21, 2020
Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instabilitySuhas S Kharat, Xia Ding, Divya Swaminathan, et al.
Molecular Cancer Therapeutics|July 8, 2025
KRAS codon-specific mutations differentially toggle PI3K pathway signaling and alter sensitivity to inavolisib (GDC-0077)Kyung W Song, Christy C Ong, Eva Lin, et al.
Cancer Letters|September 7, 2014
Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activityOliver Ou, Konrad Huppi, Sirisha Chakka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung AdenocarcinomaAnneleen Daemen, Jonathan E Cooper, Szymon Myrta, et al.
Molecular Cancer Therapeutics|March 5, 2020
CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing SarcomaGuillermo Flores, Joel H Everett, Elissa A Boguslawski, et al.
Cancer Cell|October 10, 2018
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant TumorsIvana Yen, Frances Shanahan, Mark Merchant, et al.
Cancer Discovery|November 19, 2020
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK PathwaysTrang H Pham, Thijs J Hagenbeek, Ho-June Lee, et al.
Pageof 9